Mycobacterium tuberculosis employs two-component systems (TCSs) for survival within its host. The TCS MtrAB is conserved among mycobacteria. The response regulator MtrA is essential in M. tuberculosis. The genome-wide chromatin immunoprecipitation (ChIP) sequencing performed in this study suggested that MtrA binds upstream of at least 45 genes of M. tuberculosis, including those involved in cell wall remodelling, stress responses, persistence and regulation of transcription. It binds to the promoter regions and regulates the peptidoglycan hydrolases rpfA and rpfC, which are required for resuscitation from dormancy. It also regulates the expression of whiB4, a critical regulator of the oxidative stress response, and relF, onehalf of the toxin-antitoxin locus relFG. We have identified a new consensus 9 bp loose motif for MtrA binding. Mutational changes in the consensus sequence greatly reduced the binding of MtrA to its newly identified targets. Importantly, we observed that overexpression of a gain-of-function mutant, MtrAY102C, enhanced expression of the aforesaid genes in M. tuberculosis isolated from macrophages, whereas expression of each of these targets was lower in M. tuberculosis overexpressing a phosphorylation-defective mutant, MtrAD56N. This result suggests that phosphorylated MtrA (MtrA-P) is required for the expression of its targets in macrophages. Our data have uncovered new MtrA targets that suggest that MtrA is required for a transcriptional response that likely enables M. tuberculosis to persist within its host and emerge out of dormancy when the conditions are favourable.
INTRODUCTION
Mycobacterium tuberculosis was associated with 1.4 million deaths in 2015 [World Health Organization Annual Report (http://www.who.int/tb/publications/global_report/en/)]. The bacteria persist for decades within the human host and emerge out of this dormant state under favourable conditions. The lack of effective new drugs is at least in part due to the gaps in our understanding of the cues that govern the ability of the bacterium to switch into a dormant, persistent state and to reactivate when the conditions are favourable. Our understanding of how the bacterium mounts an appropriate response to the adverse conditions within its host and how it orchestrates a reactivation process when host immunity is compromised is dependent on our knowledge of the regulation of the stress response at the molecular level.
M. tuberculosis resides in alveolar macrophages, where it encounters low pH, lack of nutrients, low oxygen, reactive oxygen species and nitrosative stress [1] . In order to adapt successfully, it employs mechanisms that enable it to sense stress and remodel its transcriptome. The two-component systems (TCSs), which include MtrAB, enable M. tuberculosis to adequately sense and respond to stress [2, 3] . MtrB is the sensor kinase and MtrA is the response regulator of the MtrAB TCS [2] . The chromosomal copy of mtrA can only be disrupted by homologous recombination in the presence of an additional copy of mtrA on a conditionally replicating mycobacterial plasmid, which suggests that mtrA is essential [4] . MtrA interacts with the promoters of oriC, fbpB, ripA, rpfB and dnaA [5] [6] [7] [8] . MtrAB is the likely functional homologue of the YycFG TCS in Bacillus subtilis [9] . The YycFG system controls several pathways involved in cell wall synthesis and division [10, 11] . Among the genes likely to be regulated by MtrA, the ripA and rpfB genes encode hydrolytic enzymes that facilitate peptidoglycan remodelling and division into two daughter cells [12] . The resuscitation promoting factors (Rpfs) are not required for growth in cultures [12, 13] , but play critical roles in persistence during infection in vivo [14] . In our previous studies, we demonstrated that the expression of rpfB is regulated by MtrA [8] . It is possible that the essentiality of mtrA is linked to the importance of its targets in cell wall homeostasis and in replication. YycFG of B. subtilis, a regulator of cell wall synthesis and cell division, is also essential [15] . However, a detailed understanding of the MtrA regulon will provide better insight into the reasons for its essentiality. We also lack knowledge of the signals sensed by MtrB. In M. smegmatis, the lipoprotein LpqB interacts with the extracytoplasmic domain of MtrB [16] . This interaction is associated with the phosphorylation of MtrA. It has been demonstrated in a bacterial two-hybrid system. Its relevance in M. tuberculosis remains to be tested.
In order to gain a more comprehensive understanding of the MtrA regulon, we performed genome-wide chromatin immunoprecipitation (ChIP) combined with next-generation sequencing using an M. tuberculosis strain overexpressing His-MtrA. Considering the link between MtrAB and cell wall remodelling, we focused on the putative MtrA targets rpfA and rpfC. We have validated the binding of MtrA to the rpfA and rpfC promoter regions, mapped the binding sites of MtrA on these promoters and demonstrated that rpfA and rpfC are likely regulated in an MtrA-dependent manner in M. tuberculosis grown in macrophages. Taken together with our previous report, these results suggest that MtrA regulates at least three of the five rpf genes in M. tuberculosis. In addition, we have developed a consensus motif for MtrA binding, which enabled the identification of whiB4 as a novel MtrA target.
METHODS
Bacterial strains and growth conditions Cloning was performed in either E. coli Top10 or DH5a. For protein purification, E. coli C41 (DE3) or BL21 (DE3) was used. All E. coli strains were grown in Luria-Bertani (LB) broth supplemented with antibiotics as required. M. tuberculosis H37Rv (ATCC25618) was grown in Middlebrook 7H9 broth (Difco) supplemented with 0.05 % (vol/ vol) Tween 80, and 10 % albumin-dextrose-catalase (ADC) (Difco). M. smegmatis mc Maintenance of RAW264.7 RAW264.7 cells were obtained from the National Centre for Cell Science, Pune, India. The cells were maintained in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10 % foetal bovine serum (FBS) at 37 C in humidified air containing 5 % CO 2.
Molecular biological procedures
Standard procedures were used for cloning and analysis of DNA, PCR, electroporation and transformation. The enzymes used to manipulate DNA were from Roche Applied Science, Fermentas and New England Biolabs. DNA sequencing was performed using an automated DNA Sequencer (Big Dye Terminator v3.1, Applied Biosystems). All of the constructs made by PCR were sequenced to verify their integrity.
Chromatin immunoprecipitation (ChIP)
ChIP was carried out using the protocol described by Sharma et al. [8] for M. tuberculosis harbouring an empty vector (pLAM2) (control) or His-MtrA-expressing construct (mtrA :: pLAM12) [8] . The cells were grown to an A 600 of 0.4-0.5 in Middlebrook 7H9 media supplemented with 10 % ADC, 0.05 % Tween 80, 20 µg ml À1 kanamycin and 0.2 % succinate. For the induction of His-MtrA, acetamide (0.2 %) was added and the cells were grown for a further 72 h. Crosslinking was carried out as described previously. The cultures were lysed and the DNA was sheared on Bioruptor plus (Diagenode) with 25 cycles of 30/ 90 on/off, respectively, so as to generate fragment sizes of 250 bp. Immune complexes were precipitated from control cells or cells expressing His-MtrA with anti-His antibody (Abcam), and washed. The elution of DNA from total lysates (input) and immunoprecipitates (IP) was carried out as described earlier [8] . The DNA was purified and samples were used immediately for next-generation sequencing (NGS) or PCR verification.
High-throughput sequencing
ChIP-Seq libraries for sequencing were constructed at Genotypic Technology's Genomics facility according to the NEXTflex ChIP-Seq library protocol outlined in the NEXTflex ChIP-Seq kit (cat nos102-1001). The libraries were enriched using PCR followed by purification using Agencourt AMPURE XP beads (Beckman Coulter #A63881) and quality was checked on a High Sensitivity Bioanalyzer Chip (Agilent). Sequencing was performed at Genotypic Technology's Genomics facility following certified protocols from Illumina on an Illumina Nextseq platform using single-end 75 bp chemistry. The quality check of raw reads was performed using the Genotypic SeqQC v2.2 tool. The reads were aligned to the reference M. tuberculosis H37Rv genome using the Bowtie 0.12.9 alignment tool, resulting in 96 % of reads being aligned for the input samples. Peak detection was carried out using the Hypergeometric Optimization of Motif EnRichment (Homer) tool. Peaks with fourfold more normalized tags in the target experiment compared to the input were considered. The differences in tag counts were considered to be statistically significant for a cumulative Poisson P-value of 0.0001 (relative to the input tag count).
qPCR validation of ChIP
The primers designed for the qPCR validation of selected loci are given in Table S1 (available in the online version of this article). PCR was performed on ChIP as well as input DNA. Comparisons were made between His-MtrA-expressing samples and control samples obtained from M. tuberculosis harbouring pLAM12. Primers against the 16s rRNA gene were used as a negative control for the ChIP.
Purification of MtrA
His-MtrA was purified as described by Sharma et al. [8] .
Identification of the transcriptional start point (TSPs) The 5¢/3¢ RACE kit (Second Generation, Roche Applied Science) was used to identify the transcriptional start points (TSPs) as described by Sharma et al. [8] . Briefly, cDNA was synthesized from RNA using the primers given in Table S1 , followed by dA-tailing. cDNA was PCR-amplified using the oligo(dT) anchor primer and the primers given in Table S1 . The PCR product was further amplified using the PCR anchor primer (Roche) and the primers given in Table S1 . Finally, the PCR product was cloned and sequenced.
Identification of the translation start sites (TSSs) For the generation of translational fusions in pMYT131 (a generous gift from Dr Roberta Provvedi), the method of Sharma et al. [8] was used to create different translational fusions with lacZ. For confirmation of the TSSs, site-directed mutagenesis was carried using appropriate mutagenic primers (Table S1 ). b-galactosidase activity was measured for each construct transformed in M. smegmatis.
Measurement of promoter activity DNA fragments extending upstream of the genes were PCR-amplified and cloned between the BamHI and KpnI sites of pFPV27 [17] . The resulting constructs or pFPV27 were electroporated separately into M. tuberculosis. GFP fluorescence was measured as described previously [18] . Briefly, M. tuberculosis carrying promoter-gfp fusions was grown in Middlebrook 7H9 broth containing 0.05 % (w/v) Tween 80 and 10% ADC up to mid-log phase (A 600 0.4-0.6). The cells were pelleted, washed twice and resuspended in PBS to an A 600 of 20. The cells (0.1 ml) were transferred to black 96-well plates (Perkin-Elmer) and GFP fluorescence was measured using a fluorescence microplate reader (Victor 1420 multilabel counter) with excitation at 488 nm and emission at 535 nm. Comparisons were made between cells expressing different promoter fusions and cells harbouring pFPV27 only. Student's t tests were used for statistical analyses.
Mycobacterial expression of His-MtrA MTB pLAM12 or mtrA :: pLAM12 was electroporated separately into M. tuberculosis as described by Sharma et al. [8] . Mutants of His-tagged mtrA were generated by overlap extension PCR using appropriate primers (Table S1 ). Expression of mutant His-MtrA (Y102C or D56N) was confirmed by Western blotting of bacterial lysates with anti-His antibody.
Streptavidin pull-down assay
The association of His-MtrA expressed in M. tuberculosis with biotinylated DNA fragments derived from the selected promoters was analyzed after the incubation of cell-free lysates with biotinylated DNA, followed by pull-down with streptavidin-conjugated agarose, as described by Sharma et al. [8] .
Phosphorylation of MtrA by EnvZ kinase and EMSA MalE-EnvZ was purified and phosphotransfer reactions were carried out as described by Sharma et al. [8] . EMSAs were performed and DNA-protein complexes were visualized as described [8] . Each DNA was amplified using primer pairs containing one Cy5-labelled primer (Table S1 ). For EMSAs using oligonucleotides, complementary strands were annealed by mixing in equimolar ratios in TE containing 50 mM NaCl. dsDNA was purified by PAGE and radiolabelled using g 32 P-ATP and T4 polynucleotide kinase. All experiments were carried out with phosphorylated MtrA (MtrA-P) based on earlier reports that MtrA-P binds with higher efficiency to its promoters than MtrA [5] .
Quantitative real-time (qRT)-PCR cDNA was synthesized from RNA using the RevertAid reverse transcriptase for first strand cDNA synthesis. SYBR Green-based qRT-PCR was performed with KAPA SYBR FAST qPCR kit MasterMix, using appropriate primers (Table S1 ). The relative expression of various genes was normalized to that of the endogenous reference 16S rRNA gene and the fold change in expression was calculated using the comparative Ct method. P-values were calculated using the Student's t-test.
Infection of RAW264.7, isolation of RNA from intracellular bacteria and determination of c.f.u.s RAW264.7 cells were seeded at 10 7 cells per T75 flask in four flasks for each strain. Various genetically manipulated derivatives of M. tuberculosis were grown and induced with acetamide for the expression of MtrA as described above. Bacteria were harvested, washed in PBS, resuspended in Dulbecco's modified Eagle's medium (DMEM) with 10 % FBS and used for infection. RAW cells were infected at an m.o.i. of 10 for 4 h followed by treatment with gentamicin for another 2 h to remove extracellular bacteria. Macrophage monolayers were washed in PBS and RNA was prepared from intracellular bacteria following the method of Rohde et al. [19] . Briefly, RAW cells were lysed in GTC buffer containing N-lauryl sarcosine, sodium citrate and b-mercaptoethanol. Lysates were centrifuged and the bacterial pellet was lysed by the addition of lysozyme and Trizol followed by bead beating. RNA was prepared by chloroform extraction followed by application to an RNeasy kit column (Qiagen). RNA was treated with DNAse and purified.
For the determination of colony-forming units (c.f.u.s), infected cells were lysed and serial dilutions of homogenates were plated on Middlebrook 7H11 agar plates supplemented with 10 % OADC and incubated at 37 C for 3-4 weeks. The c.f.u.s were calculated in triplicate using standard procedures.
RESULTS
M. tuberculosis harbouring either the empty vector pLAM2 (control) or the plasmid mtrA :: pLAM12 was induced with acetamide and immunoprecipitations were carried out with anti-His antibody as described in the Methods section. Following ChIP using anti-His antibody, NGS was performed with the eluted DNA. A quality check of 10 million 50-nucleotide reads was performed using seqQC v2.2 and the coverage on the genome of M. tuberculosis was calculated using the Bowtie alignment tool [20] . The number of reads at each point was normalized to the total number of reads of the sample. The peak calling tool was used to identify enriched regions (150 bp or more) in the immunoprecipitated sample, taking the total lysate (input) as background control. Regions showing at least 2.5-fold enrichment (P=0.002) were selected for further analysis. Analysis of the sequencing data suggested that MtrA may bind to the upstream regions of at least 45 genes in exponentially growing M. tuberculosis (Table S2a ). The in silico analyses showed the presence of regions specifically enriched in the IP samples expressing MtrA (IP-His-MtrA), which were absent in the control samples (obtained from M. tuberculosis harbouring the empty vector) (IP-Control) (Fig. S1a) . Functional classification showed that 20 % of the targets identified belonged to cell wall and cell processes, while 9 % were classified under virulence, detoxification and information pathway; 20 % of the targets belonged to the conserved hypotheticals (Fig. S1b) .
Validation of the results of ChIP-seq by q-PCR
To independently confirm the binding of MtrA to the loci identified in the ChIP-seq analysis, the binding sites upstream of several genes were selected for validation by qPCR. Representative genes were selected from the following pathways: cell wall and cell processes (rpfA and rpfC); information pathway (rpoB); and virulence, detoxification and adaptation (relF). The regions amplified were chosen from putative promoter regions of the respective genes based on the binding information obtained from ChIP-seq (Table S2a) . Enrichment was confirmed for rpfA, rpfC, rpoB, relF and rpfB promoter regions (Fig. 1a) , suggesting that MtrA functions as a likely transcriptional regulator of the aforesaid genes. Semi-quantitative PCR analysis indicated enrichment of MtrA-binding sites on the upstream sequences of Rv2524c and Rv3246c (mtrA) (Fig. S1c) , but not sequences within the coding region of the 16s rRNA gene, which served as a negative control.
MtrA binds to the promoters of rpfA and rpfC Based on the ChIP enrichment data and qPCR validation, we chose a subset of putative MtrA-regulated genes for further analyses. Taking into account the fact that in most cases the phosphorylated response regulator binds with higher affinity to its specific DNA compared to the nonphosphorylated protein, we tested the binding of MtrA-P to a chosen set of putative promoter DNA fragments. The Rpfs are important in view of the role they play in the reactivation of M. tuberculosis [21] . Here we tested the probable regulation of rpfA and rpfC by MtrA. MtrA-P bound to a fragment encompassing the region À277 to À114 [DNA1] (Fig. 1b) upstream of the annotated translational start site (TSS) of the rpfA gene in a concentrationdependent manner (Fig. 1c) . The binding of MtrA-P to DNA1 could be competed using an unlabelled oligonucleotide (Fig. S2a) , confirming the specificity of the interaction. MtrA-P did not bind DNA2 [À167 to À114] (Fig. 1d) , suggesting that the region À277 to À167 likely harbours the MtrA-binding site. In a similar vein, we also tested the binding of MtrA-P to the rpfC promoter region using different fragments derived from the rpfC promoter region (Fig. 1e ). MtrA-P could bind DNA3 (Fig. 1f) . This could be competed with unlabelled DNA3 (Fig. S2b ). MtrA-P could also bind to DNA4 (Fig. S2c) but not to DNA5 (Fig. 1g) , suggesting that the MtrA-binding site resides within the region À308 to À186. In order to further narrow down the MtrA-binding regions on the rpfA or rpfC promoters, MEME software was employed. Loose direct repeats were identified in the regions À277 to À167 or À308 to À186 of the rpfA or rpfC promoter, respectively. Radiolabelled oligonucleotide 1 (oligo 1) (Fig. 1h) encompassing the repeat derived from the rpfA promoter showed binding with MtrA-P (Fig. 1j) , which could be competed with unlabelled oligo 1 (Fig. S2d) . The importance of the identified repeat (À245 to À227) was tested. The removal of one repeat (oligo 2) did not show a marked alteration of binding of MtrA-P (Fig. S2e) . Mutations within both the repeats (oligo 3) led to the loss of binding of MtrA (Fig. 1k) . For rpfC, radiolabelled oligo 4 encompassing the repeat showed binding with MtrA (Fig. 1l) . This binding could be competed with unlabelled oligo 4 (Fig. S2f) . Binding was abolished either in the absence of one-half of the repeat (oligo5) (Fig. S2g) or when both of the repeats were mutated (oligo 6) (Fig. 1m) . These results confirmed the identification of the direct repeat that is critical for the binding of MtrA to the promoter of rpfC.
MtrA regulates rpfA and rpfC transcription In order to ascertain the position of the MtrA-binding region with respect to the transcriptional start points (TSPs) of rpfA and rpfC, RNA from exponentially grown M. tuberculosis was subjected to 5¢-RACE. For both rpfA and rpfC, a single TSP was obtained (a 'G' for rpfA and an 'A' for rpfC) (Fig. S3a, b) The TSS of rpfA was determined by creating a translational fusion between the putative start codon and lacZ in the vector pMYT131, which lacks its own start codon. b-galactosidase activity observed in the transformant was abolished upon mutation of the ATG start codon to AAG (Fig. S4a, b) , confirming the TSS of rpfA. The TSS of rpfC was similarly identified and confirmed by mutating the 'GTG' to 'GAG' (Fig. S4c, d ). This TSS identified by us is 233 bp downstream of the annotated TSS and 120 bp downstream of our identified TSP. In this study, we did not carry out mutational analysis of the annotated TSS. We do not rule out the possibility that multiple TSSs exist for rpfC.
In order to strengthen the contention that MtrA regulates rpfA by binding to the regions identified above, a fragment À600 to +1 (rpfA1) or À600 to +1 harbouring a mutated MtrA-binding site (rpfA2) (Fig. 2a) was cloned into a promoterless gfp vector. GFP fluorescence was significantly reduced in transformants harbouring rpfA2 (with a mutated MtrA-binding site) compared to rpfA1 (Fig. 2b) , confirming the importance of the MtrA-binding region in driving expression of the rpfA promoter and increasing the likelihood of MtrA-dependent activation of rpfA. Fusion of the region À600 to À299 (rpfA3) (Fig. 2a) , lacking the TSP, failed to drive gfp expression (Fig. 2b) . We also generated fusions of various regions of the rpfC promoter to gfp (Fig. 2c) . The mutation in the region harbouring the MtrAbinding site (between À277 to À257) showed significantly reduced GFP fluorescence (Fig. 2d) , indicating that MtrA probably has a regulatory role in driving rpfC expression. Pull-down assays were used to further confirm the binding of MtrA to the regions of the rpfA and rpfC promoter specified above. His-MtrA expressed in M. tuberculosis could be pulled down by biotinylated oligonucleotides encompassing the À614 to À19 region of the rpfA promoter (rpfA MtrA WT) (Fig. 2e) or the À329 to À130 region of the rpfC promoter (rpfC MtrA WT) (Fig. 2f) . In either case, deletion of the MtrA-binding sites (rpfA MtrA-del or rpfC MtrA-del) abolished the ability of the oligonucleotides to pull down His-MtrA.
MtrA regulates rpfA and rpfC during the infection of macrophages by M. tuberculosis We attempted to test the role of MtrA during the infection of macrophages by M. tuberculosis. Since MtrA is essential, we attempted to knock it down conditionally. However, these attempts were unsuccessful. We therefore chose an alternative strategy to further test the role of MtrA by expressing MtrA Y102C , a gain-of-function mutant [22] in M. tuberculosis. We overexpressed His-MtrA Y102C in M. tuberculosis under the control of acetamidase promoter (Fig. S4e, f) . Overexpression of MtrA Y102C did not alter the viability of M. tuberculosis in infected macrophages (Fig.  S4g) . We evaluated the expression of the MtrA targets rpfA and rpfC in Mtb residing in macrophages. Both rpfA and rpfC were upregulated by >4-and >2-fold, respectively, in cells expressing MtrA Y102C compared to M. tuberculosis harbouring pLAM12 (Fig. 3a) . As a control, we observed downregulation of the previously characterized MtrA target fbpB. In order to pinpoint the role of MtrA in the transcription of rpfs, we transformed M. tuberculosis with a plasmid encoding a phosphorylation-defective mutant, MtrA D56N [22] , under the control of the acetamidase promoter (Fig. S4e, f) . Broker et al. [23] demonstrated that substitution of the conserved residue D at the equivalent position in Corynebacterium glutamicum leads to loss of MtrA DNA-binding activity. The levels of rpfA and rpfC were significantly reduced upon overexpression of MtrA D56N compared to the levels observed in the case of overexpression of MtrA Y102C (Fig. 3b) , although the levels of expression of His-MtrA (Fig. S4e, f) and the viability of bacteria in macrophages (Fig. S4g) were comparable to those for the strain overproducing MtrA Y102C . The relative fold change in the case of MtrA D56N was small but significant in our study. In summary, our results support the view that MtrA plays an important role in regulating the expression of rpfs in M. tuberculosis residing in macrophages.
MtrA-P binds to the relF and rpoB promoters In order to expand the repertoire of genes harbouring MtrA-binding sites in their upstream regions, we tested additional hits obtained from the ChIP-seq data. TA modules are ubiquitous in bacteria and play central roles in persistence and dormancy. The M. tuberculosis genome encodes three Rel TA modules: RelBE Mtb , RelFG Mtb and RelJK Mtb . ChIP-seq (Table S2a) suggested that MtrA binds to the putative promoters of relF as well as rpoB, encoding the beta subunit of RNA polymerase. This was confirmed by qPCR (Fig. 1a) . The TSP of relF was determined (Fig. S3c) . In EMSAs, MtrA-P bound to DNA6 (encompassing the À267 to À105 region of the relF promoter) (Fig. 4a, b) . This binding could be competed by unlabelled DNA6 (Fig. S5a ). MtrA-P could also bind DNA7 and DNA8 (Fig. S5b, c) . Binding was partly decreased with DNA9 (Fig. 4c) , whereas no binding was observed with DNA10 ( Fig. 4d) , suggesting that the MtrA-binding site resides within the region À222 to À179. In order to further pinpoint the MtrA-binding site on the relF promoter, EMSAs were carried out with an oligonucleotide containing a putative binding repeat (oligo 7) (Fig. 4e ). MtrA-P bound to oligo 7 in a concentrationdependent manner (Fig. 4f) and the binding could be competed using excess unlabelled oligo 7 (Fig. S5d) . Binding was compromised with an oligonucleotide lacking one repeat (oligo 8) (Fig. S5e) and abolished when both of the repeats were mutated (oligo 9) (Fig. 4g) . In an attempt to elucidate the role of MtrA in relF expression, different amplicons were cloned into pFPV27 (Fig. S5f) . GFP fluorescence was obtained in a construct encompassing the region À323 to +80 (relF-1) (Fig. S5g) , but abolished in a relF promotergfp construct lacking the TSP (relF-2), and also in a construct (relF-3) where the predicted MtrA-binding site was mutated (Fig. S5g) . The possible relevance of MtrA-dependent regulation of relF was further indicated by the observation that relF expression was augmented in M. tuberculosis expressing MtrA Y102C residing in macrophages, and repressed in M. tuberculosis expressing MtrA D56N , compared to M. tuberculosis harbouring pALM12 (Fig. 3a, b) . Taken together, these results raised the probability that MtrA is a regulator of relF in M. tuberculosis grown in macrophages.
rpoB encodes the beta subunit of RNA polymerase, which is a target of the drug rifampicin. ChIP-seq (Table S2a) and qPCR (Fig. 1a) suggested that rpoB is a possible target of MtrA. We validated the binding of MtrA to the rpoB promoter region by showing that MtrA binds to the À200 to +1 region (Fig. 4h) in a concentration-dependent manner (Fig. 4i) . Binding could be competed with unlabelled DNA11 (Fig. S5h) . MtrA-P bound to the region À150 to +1 [DNA12] (Fig. S5i) , but not to the region À87 to +1 [DNA13] (Fig. 4j) , which lacks a loose repeat (CGTGCGTGAGATCCGGACA-GATCGTTCGCCGG) within positions À119 to À101. Identification of an MtrA-binding motif The sequences corresponding to the MtrA-binding regions identified upstream of the genes discussed above were compiled and a loosely base-paired 9 bp motif was generated using Weblogo 3.5.0 (Fig. 5a ). This motif is depicted upstream of previously reported MtrA target genes (Fig.  S6a) , as well as the rpfA, rpfC and relF analysed in this study (Fig. S6b, c) . In all, 84 % of the targets identified in the genome-wide analysis presented in this study (Table S2b) showed the presence of the aforesaid MtrA-binding motif in (Table S2c) showed the presence of the MtrA-binding motif presented in this study.
Validation of additional binding sites
In order to test the robustness of the motif identified by us (Fig. 5a) , we tested the binding of MtrA to at least one of the upstream regions that was documented by Minch et al. [24] , but absent from our ChIP-seq analysis. Here we focus on the motif we identified upstream of whiB4. The WhiB family of proteins of M. tuberculosis represent Fe-S clusterbased transcription factors that regulate the response of M. tuberculosis to oxidative or nitrosative stress [25, 26] . ChIP-PCR analysis confirmed the binding of MtrA to the region À136 to +14 of whiB4 (Fig. 1a) . The TSP of whiB4 was determined at position À8 by 5¢-RACE (Fig. S3d) . In EMSAs, MtrA-P bound to DNA encompassing the region À136 to +14 (DNA 14) (Fig. 5b, c) . The binding could be competed with excess unlabelled DNA 14 (Fig. S6d) . In order to narrow down the MtrA-binding region, shorter fragments were tested for their ability to bind MtrA. DNA 15 (À61 to +14) lacking the predicted repeat motif (À134 to À117) failed to bind to MtrA-P (Fig. 5d ). MtrA-P could bind an oligonucleotide encompassing the region À136 to À106 (Fig. 5e, f) . Mutations within the repeat sequence abrogated MtrA binding (Fig. 5f ). Various gfp fusion constructs were generated in order to test the ability of whiB4-derived promoter fragments to drive GFP fluorescence (Fig. 5g) . The region À220 to +80 fused to gfp in pFPV27 (whiB4-1) was able to drive GFP fluorescence (Fig. 5h) . On the other hand, a construct lacking the identified TSP (À220 to À19) (whiB4-2) was unable to drive GFP fluorescence. GFP fluorescence was compromised in a construct lacking the MtrA binding repeat (whiB4-3) (Fig. 5h) . Taken together, these observations suggested that MtrA binds to the whiB4 promoter to regulate whiB4. These results strengthen the view that the MtrA-binding motif identified by us (Fig. 5a ) may be employed to identify further MtrA targets in M. tuberculosis.
DISCUSSION
Inside the macrophage, M. tuberculosis must regulate replication, transcription and translation, as well as cell wall synthesis and division, so that it can switch to a dormant state when the conditions are not favourable, while retaining the ability to reactivate when the conditions become favourable. This regulation is orchestrated by an arsenal of sensors and transcriptional regulators. One such transcriptional regulator is MtrA, an essential gene of M. tuberculosis. ChIP-seq was employed to identify genome-wide MtrA-binding sites in M. tuberculosis in order to expand the set of MtrA-binding genomic loci. In this study, we focused on (a) validating the binding of MtrA to upstream regions of a set of genes of importance in the establishment of infection, (b) analysing the likely relevance of binding in a physiological context and (c) identifying an MtrA-binding motif.
Analyses of genome-wide MtrA binding by ChIP-seq has been carried out previously in M. tuberculosis overexpressing FLAG-MtrA [24, 27] . We compared the data presented by Minch et al. [24] with the results of our present study. Minch et al. [24] reported 89 MtrA targets in their study as compared to the 45 targets identified by us. Eighteen targets were found to be common to both of the studies, whereas the remaining 27 targets reported by us were unique ( Table S2d ). The differences in ChIP-seq data between the two studies could possibly be due to the following reasons. In our study, N-terminal His-tagged MtrA was induced for 72 h under the control of the acetamidase promoter, whereas Minch et al. [24] expressed C-terminal FLAGtagged MtrA under the control of the tetracycline promoter for 18 h. Moreover, for the analysis of the genome-wide binding profile of MtrA, we used a cutoff value of P<0.002 which is more stringent than that used by Minch et al. (P<0.01). Based on both these two studies, a total of 114 genes were found to be probable MtrA targets. Out of the targets identified by ChIP-seq in this study, rpfA (Rv0867c), rpfC (Rv1884c) and mtrA (Rv3246c) were also listed as MtrA targets by Minch et al. [24] . On the other hand, relF (Rv2865), rpoB (Rv0667) and fas (Rv2524c) were not reported to be putative targets of MtrA by Minch et al. whiB4 (Rv3681c) was identified as an MtrA target by Minch et al. It was absent in our global ChIP-seq analysis. However, an MtrA-binding motif was identified by us in the region upstream of whiB4, and the likely importance of MtrA binding to this region was demonstrated using EMSAs and GFP reporter assays. The work by Minch et al. [24] only validated the binding of MtrA to the upstream region of one target, Rv0494, by EMSA. On the other hand, we validated the binding of MtrA to the upstream regions of a number of additional genes by ChIP-qPCR and EMSA.
The Rpfs are peptidoglycan hydrolases that cleave the bÀ1,4 glycosidic bond in the glycan backbone of peptidoglycan. Rpfs stimulate the resuscitation of dormant mycobacteria [12] . Transcriptional analysis has shown increased expression of rpfA and rpfC during early resuscitation and hypoxia, respectively [28] . Our previous studies indicated that MtrA represses rpfB [8] . RpfA has been reported to exhibit activity at femtomolar concentrations [29] . rpfA is regulated by cAMP receptor protein [30] . Here we further characterized the rpfA promoter by determining the TSP and TSS and confirming the binding of MtrA to rpfA promoter-derived DNA by EMSA. Compromised binding of MtrA to oligonucleotides carrying substitutions in the putative MtrA-binding repeat strengthened the characterization of the MtrA-binding site on the rpfA promoter. GFP reporter assays carried out with native rpfA promoterderived fragments as well as substitution constructs lacking putative MtrA binding sites suggested that MtrA likely activates rpfA transcription. Little is known about the regulation of rpfC transcription. In this study, we identified the TSP of rpfC and performed GFP reporter assays and pulldowns of MtrA with biotinylated DNA derived from the rpfC promoter to confirm that MtrA binds to the rpfC promoter and regulates its expression. Substitutions in the putative MtrA-binding repeat abolished MtrA binding to the rpfC promoter. The TSP appeared to be located downstream of the annotated TSS, but upstream of the TSS identified by us (Fig. S4d) . Our annotation is supported by the report on the SigD-binding site on the rpfC promoter by Raman et al. [31] . The SigD-binding site determined by Raman et al. is located precisely at the À10 and À35 regions of the TSP determined by us, supporting our identification of the TSP. Binding of MtrA therefore occurs upstream of the TSP and is associated with the activation of rpfC. However, we do not rule out the possibility of there being additional TSP(s) upstream of the annotated start codon.
The distinct functions of the five different Rpfs of M. tuberculosis remain poorly understood. RpfB interacts with RipA, a DL-endopeptidase [32] . The interacting partners of the other Rpfs remain to be characterized. The conditions triggering expression of these Rpfs and their interactions with specific partners are likely intimately connected to the phenomena of dormancy and reactivation. It is interesting to note that MtrA is a likely repressor of rpfB but an activator of rpfA and rpfC. It is likely that these gene products have functions distinct from their roles in dormancy and reactivation. Several Rpfs have additional domains on top of their shared, conserved lysozyme-like domain of around 70 amino acids. For example, RpfA carries, besides the Rpf-like domain, a series of alanine-rich repeats [33] . The function (s) of this repeat is not clear. RpfB interacts with RipA to regulate cell division. It is possible that these additional domains and functions require distinctly different mechanisms of regulation to ensure successful survival of the bacterium, possibly accounting for the fact that MtrA represses rpfB but activates rpfA and rpfC. The implications of these observations deserve further investigation. It may also be noted that binding of MtrA was not detectable in the upstream regions of rpfD and rpfE, either in this study or in the report by Minch et al. [24] .
We analysed the role of MtrA in the expression of its targets in bacteria grown within macrophages. Substitution of D with N at position 56 leads to a defect in the phosphorylation of MtrA of M. tuberculosis and C. glutamicum [22, 23] . On the other hand, substitution of Y with C at position 102 generates a gain-of-function mutant of MtrA [22] . We infected macrophages with M. tuberculosis expressing either the gain-of-function or the phosphorylation-defective mutant of MtrA, and determined the extent of transcription of the newly identified targets of MtrA. Our results suggest that MtrA regulates the transcription of its targets in M. tuberculosis grown in macrophages in a phosphorylation-dependent manner. Our data corroborate earlier findings demonstrating that MtrA activates the transcription of dnaA in its phosphorylated form [5] .
Based on ChIP-seq analysis, we tested the role of MtrA on two more targets, relF and rpoB. Toxin-antitoxin (TA) systems are composed of a protein toxin and an antagonistic antitoxin, which normally keeps the toxin activity in check [34] . Under specific conditions of stress such as DNA damage, oxidative stress, starvation or exposure to antibiotics, the labile antitoxin is degraded, allowing the free toxin to target key processes such as cell wall synthesis, cell division, DNA replication or translation. M. tuberculosis has three RelBE-like modules, namely, relBE (Rv1247c-Rv1246c), relFG (Rv2865-Rv2866) and relJK(Rv3357-Rv3358) [34] . RelE, relF and relK are expressed during the infection of human macrophages [35] . Understanding the transcriptional regulation of these gene pairs is therefore of importance for our understanding of the mycobacterial stress response. As observed in the case of the rpfs, the transcription of relF was increased in M. tuberculosis residing in macrophages in a phosphorylation-dependent manner. In the light of the predicted roles of the relBE gene family in mycobacterial persistence, the regulation of the relFG operon by MtrA raises questions about its possible relevance to the intracellular lifestyle of M. tuberculosis that are worth exploring in future.
Another important probable target of MtrA is rpoB encoding the beta subunit of RNA polymerase of M. tuberculosis. Rifampicin, one of the most widely used drugs for the treatment of tuberculosis, interferes with transcription by binding to the beta subunit of RNA polymerase. Rifampicin-resistant strains showed mutations in rpoB [36] . We validated the binding of MtrA to the rpoB promoter.
We identified an MtrA-binding motif that showed some degree of overlap with the motifs identified other laboratories [5, 37] . This motif was identified in several MtrA-regulated promoters previously reported by other laboratories, as well as the promoters validated in this study. Based on our motif logo, we chose to test and validate MtrA binding to whiB4. WhiB4 controls the activation of the antioxidant response by regulating the expression of antioxidant genes such as ahpC, ahpD, rubA and pqqE under oxidative stress in mycobacteria [25] . MtrA binding to the whiB4 promoter and regulation of its promoter activity is of obvious importance.
The detailed DNA-binding studies and promoter analyses carried out in this study, as well as the analyses of MtrA targets in M. tuberculosis residing in macrophages, strengthen the view that MtrA regulates a repertoire of genes of significance to the mycobacterial stress response and the ability of M. tuberculosis to survive and replicate within its host. The conditions under which MtrA regulates the aforesaid genes merit detailed investigation. 
